FDA Drug Directory Dangerously Incomplete: Report

Law360, New York (August 15, 2006, 12:00 AM EDT) -- A report has found that the Food and Drug Administration’s national drug directory is sorely incomplete because it omits thousands of drugs while including thousands of others that have long gone off the market.

“The failure of firms to list drug products with FDA limits the usefulness of the directory to all who rely on it for timely information about prescription drugs on the market,” said the report, issued this month from the Department of Health and Human Service’s Office of the Inspector General.

The FDA’s...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.